ROCÍO
GARCÍA CARBONERO
Profesora asociada de Ciencias de la Salud
Merck Institute for Science Education
Rahway, Estados UnidosPublications en collaboration avec des chercheurs de Merck Institute for Science Education (2)
2022
-
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
The Lancet Oncology, Vol. 23, Núm. 5, pp. 659-670
2020
-
Pembrolizumab in microsatellite-instability-high advanced colorectal cancer
New England Journal of Medicine, Vol. 383, Núm. 23, pp. 2207-2218